Derivatives of manumycin(1) were obtained by acetylation and reduction, respectively, and characterized by their spectroscopic data. Structure-activity relationships of the antibiotic were discussed.
. Rfvalues ofmanumycin (1) , its acetates 2 and 3, the "hydromanumycins" 10, 12 and 14, their methanolysis products ll and 13, and the deoxymanumycins 7 and 8 in different solvent systems on TLCsilica gel plates. chloroform solution of 2 for two days. In the XHNMR spectrum of this product only one acetyl singlet at 5 2.28 was observable. The missing 3"-OHsignal and the appearance of 2"-NH(d 7.97) were in accordance with structure 3. Reduction of the Cyclohexenone Epoxide Moiety As described in the preceding paper3), the reduction of manumycin (1) with sodium borohydride in aqueous methanol yielded dihydromanumycin (partial formula 6). Using dry methanol (as a reaction solvent) a yellow product precipitated and was purified by Sephadex LH-20 column chromatography. It was less soluble than 1 and found to be deoxymanumycin (7). The XHNMRspectrum of 7 in acetone-J6 exhibited no epoxide protons. The signals of two phenolic hydroxy groups at d 8.88 and 9.91 close to the amide-NH (<5 8.72 and 9.09) as well as a singlet of one aromatic proton at d 6.53 appeared additionally. The doublet of 3-H in 1 diminished to a singlet in 7 (d 7.66); all the other protons gave identical signals in both compounds. These data located the alteration of the molecule in the cyclohexene epoxide moiety, which was changed to a tetra-substituted phenolic system. The /rara-position of the remaining aromatic protons was shown by its coupling constants, being smaller than 1 Hz. The XHNMRdata, in connection with the molecular ion at m/z 534 detectable in the electron impact mass spectrum (EI-MS), as well as its elemental analysis showed the molecular formula to be C31H38N2O6. In comparison to 1 this indicated the lack of one oxygen.
The reduction of manumycin (1) with sodium borohydride started at the C-l carbonyl group, followed by an elimination of water and the regioselective opening of the epoxide. The energetically favored aromatization, which sometimes already took place during the chromatographic purification of dihydromanumycin (6), is probably the driving force. Deoxymanumycin (7) was also produced, in lower yields, via reaction of 1 with potassium iodide in acetic acid. In addition, a second reduction product was isolated, which becamethe main product using zinc dust in acetic acid. Its physico-chemical properties showed exeat similarities to those of 261 (40,200) 6. The elemental analysis pointed out the lack of a second oxygen in the molecular formula, leading to dideoxymanumycin(8), which was acetylated by applying acetic anhydride and sodium acetate to its triacetate 9. The same reaction conditions converted 1 to its diacetate 2, and the spectral data displayed the full acetylated C5N-moiety as described in 2 and 5. Additionally, an aromatic acetoxy group (d 2.32) and three aromatic protons were detectable in the XHNMRspectrum of 9. The epoxide protons were missing. NOV. 1987 Hydrogenation Depending on the reaction conditions catalytic hydrogenation of manumycin(1) led to three main products with varying yields. As a key substance for the structure elucidation "hydromanumycin" was isolated2), which now is established to be decahydrodideoxymanumycin (10). Its molecular formula C31H46N2O5 was established by high resolution mass spectrometry. Important fragment ions were found at m/z 332, 220 and 122 by successive losses of C13H24O (C13-side chain), C5H6NO2 (C5N-moiety) and C6H10O(C7-side chain splitted in benzyl-position) from the molecular ion. The structure of 10 was established both by its^NMRspectrum and the degradation product ll, liberated by acidic methanolysis in addition to the C5N-moiety 4, the latter being isolated as the triacetate 5. In acetone-<i6 the aromatic protons of ll were well-separated, with the chemical shifts and the coupling pattern being quite the same as in the model compound 2-acetamino-4-methylphenol.
A second hydrogenation product turned out to be decahydrodeoxymanumycin (12). The XH NMRspectrum displayed only two singlets at 5 6A6 and 6.76, suggesting the para position of the aromatic protons. The methyl ester 13, liberated by acidic methanolysis from 12, differed from ll only by its molecular weight. High resolution EI-MS (m/z 463, M+, C27H45NO5) indicated the presence of a further oxygen atom.
The third oily hydrogenation product sometimes appeared to be the main product. Its XH NMR spectrum showed no signals for olefinic/aromatic protons, which suggests the suppression of the favored aromatization. We assumethe cyclohexene 15 to be an intermediate product and further reduction resulted in tetradecahydromanumycin (14). Acidic methanolysis of 14 gave ll, which led us to the conclusion of tetradecahydromanumycin being an intermediate of the reductive pathway leading to decahydrodideoxymanumycin (10). Wepostulate 15 to be an intermediate on the way to the second aromatic reduction product, the decahydrodeoxymanumycin (12). Because of varying amounts of 10, 12 and 14 we suppose the different hydrogenation pathways of 1 will be under kinetic control. The low yield of 12 gives rise to the assumption, that the hydrogenation rate of the C-2/C-3 double bond (15 to 14) is faster than the elimination of water from compound 15. The product composition strongly depends both on the quantity ratio between 14 and 15 and on the extent of the energetic barrier leading to the aromatic nucleus. The conversion from 14 to 10 is much slower than from 15 to 12. Apparently, hydrogenation of the olefinic double bond at C-2 did not influence the attack on the cyclohexene epoxide including the regioselective opening of the epoxide. Consequently, the C13-side chain's methyl-ramification caused diastereomeric mixtures of the resulting hydrogenation products 10, 12 and 14, which was shown by the gas chromatographic separation of the C13-side chain methyl esters after alkaline hydrolysis and esterification2).
Biological Activities and Discussion
The biological activity of manumycin (1) has already been described1'^.
Acetylation of 3"-OH and 2"-NH (2 and 3) led to a decrease of the biological activity. Against Bacillus subtilis on a chemically defined medium, 3 was nearly 10-fold less active than 1 and 2. The C5N-moiety's importance is not clear yet, 2-acetamino-3-hydroxycyclopent-2-enone3) itself developed no biological activity against bacteria.
Aromatization of the former cyclohexenone epoxide ring as in deoxymanumycin (7) and dideoxymanumycin (8) caused the loss of this biological activity. The chirality of the six-membered ring and the nearly planar conformation of the molecules as well as the restricted solubilities might explain these 1 545 results. Accordingly the three hydromanumycins 10, 12 and 14 exhibited no activities against bacteria and fungi. The importance of the cyclohexenone epoxide's biological activity was evaluated additionally from dihydromanumycin (6)3). Although the main parts of the antibiotic were preserved, it showed no biological activity. This result pointed out the peculiarity of C-l concerning its biological activity. Unfortunately, we failed to open the epoxide ring or to convert it to a C-C double bond by deoxygenation without aromatization of the six-membered ring. Thus, a differentiation between the C-l carbonyl group and the epoxide ring was impossible. From these results it will be difficult to enhance the biological activity of the parent antibiotic manumycin (1) 
E xperimental General and Analytical
The same equipment was used as previously described3-*.
Manumycin Diacetate (2) To a solution of 115 mg 1 in 25 ml acetic anhydride 1.05 g sodium acetate was added and stirred for 65 hours at 36°C under nitrogen. The solution was treated with ice-water for 5 hours, filtered, evaporated and dried overnight. The dark brown product was chromatographically purified on a Sephadex LH-20 column (80 x2.5 cm), eluting with CHC13 to yield 71 mg pale yellow 2: Rf see Table  1 ManumycinMonoacetate (3) 89 mg2 were dissolved in 100 ml CHC13and stirred at room temp. After 3 days the solution was evaporated and chromatographed on a silica gel column (80 x2.5 cm, CHC13) to yield 25 mg 3 as a pale yellow amorphous powder: Rf see Table 1 olefmic protons), 7.50 (s, 2"-NH), 7.97 (s, NH). 3-Acetoxy-2-diacetylamino-2-cyclopentenl -one (5) The slightly acidic inorganic layer from the methanolysis of 10 (see below; description of compound ll) was evaporated to dryness. 3.5 ml acetic anhydride were added to this dark brown oily crude product and kept in a sealed tube at 150°C for 5 hours. The reaction mixture was evaporated and chromatographed on a Sephadex LH-20 column (80x2. Deoxymanumycin (7) In small portions 61 mg sodium borohydride were added to a stirred solution of 220 mg 1 in 50 ml dried MeOH.After 15 minutes the solution was dissolved in 150ml water, adjusted to pH 3 with 0.5 n oxalic acid and extracted with CHC13. The organic layer was dried, evaporated and NOV. 1987 chromatographically purified on a Sephadex LH-20 column (90 x2.5 cm). The column was washed with CHC13, and 7 was eluted with MeOH.This product was further purified on a Sephadex LH-20 column (90x2.5cm, MeOH) to yield 129 mg (60%) of a yellow amorphous powder: MP 209°C;
M2D°-49°(c 0.16, DMF); Rf 0.28 (CHC13-MeOH, 9:1); IR (KBr) cm "1 3410, 3380, 3260, 2960, 2925, 1690 (sh) , 1605 (sh), 1580, 1530, 1005; UV absorption bands see Table 2 20.7 (q, 16.4 (q, 14.2 (q, 13.7 (q, MS (70eV) Dideoxymanumycin (8) a): 500mg 1 and 1 g potassium iodide were dissolved in 40ml acetic acid and stirred for 5 minutes at 60°C. The dark red solution was mixed with 100 ml MeOHand chromatographed on Dowex1-X2, eluted with MeOH.The main yellow fraction was evaporated and chromatographed on Sephadex LH-20 (80x2.5, CHC13) to yield 43 mg (9.1 %) 8 and 96 mg (19.8%) 7. b): 500mg 1 were dissolved in 50ml acetic acid, stirred at room temp after adding 1 g zinc dust for 5 hours, and then filtered. The reaction mixture was dissolved in 500 ml water and the organic layer was extracted with CHC13, dried, evaporated and purified by column chromatography on silica gel (20x4.8cm, CHC13-MeOH, 95:5) to yield 92.1 mg (20%) 8 and 50.8mg (11%) 7. Dideoxymanumycin crystallized from CHC13 forming yellow needles: MP 219°C; M2D°-38°(c 0.15, DMF); Rf 0.55 (CHC13 -MeOH, 9:1); IR (KBr) cm "1 3570 (sh), 3370, 3260, 1670 (sh), 1630 (sh), 1625, 1616, 1600 (sh) ; UV absorption bands see Table 2 .
Anal Calcd for C31H38N2O5 : C 71.80, H 7.39, N 5.40. Found: C 71.06, H 7.25, N 5.10. Dideoxymanumycin Triacetate (9) 3 g sodium acetate, 140 mg 8 and 30 ml acetic anhydride were stirred at room temp for 84 hours, treated for 2 hours with 3 g sodium acetate in water, and extracted with CHC13. The dried organic layer was chromatographed on a Sephadex LH-20 column (100 x 2.5 cm, CHC13) and recrystallized from w-pentane to yield 76.6 mg 9 as an amorphous powder: Rf 0.78 (CHC13 -MeOH, 9 : 1); IR (KBr) cm "1 3360, 1770, 1720 (sh) Hydrogenation of Manumycin (1) 1.6 g 10% palladium on charcoal were added to a stirred solution of 1.0 g 1, dissolved in 330 ml MeOH.The hydrogenation was carried out with H2 at 21°C and 750 Torr. After 20 minutes, the solution was filtered and evaporated to yield 840 mgof a yellow oil. This was chromatographed on a silica gel column (22 x7.8 cm, eluting with CHC13-MeOH,95 : 5). Three main products, decahydrodideoxymanumycin (10), decahydrodeoxymanumycin (12) and tetradecahydromanumycin (14), were isolated.
Decahydrodideoxymanumycin
(10)
First, 125 mg (13%) of colorless oily 10 were eluted from the silica gel column and crystallized after leaving at room temp for a while: MP 93-95°C; Rf see Table 1 ; IR (KBr) cm "1 3367, 3215, 3145, 1689, 1653, 1618, 1600, 819 ; UV see Table 2 ; 2H NMR(100 MHz, CDC13) 8 0.95 (m, 9 aliphatic protons), 1 -2 (m, 23 Decahydrodeoxymanumycin (12) The second product eluting from the silica gel column was the pale yellow amorphous powder 12 (112mg, 11%): Rfvalue see Table 1 Tetradecahydromanumycin (14) 343 mg (34%) of the yellow oily tetradecahydromanumycin were obtained after hydrogenation; this compound was the last to be eluted from the silica gel column: Rf value see Table 1 ; IR (KBr)
